I obtained my BSc in Biomedical Sciences in 2018, followed by my MSc in Biomedical Sciences – disease mechanisms in 2020, both at the University of Algarve. I’ve also obtained a post-graduation in experimental approaches in Biomedicine at the University of Algarve in 2021. During my master’s thesis I designed and developed several novel CRISPR/Cas9-based tools aiming to treat a rare polyglutamine neurodegenerative disorder, named Spinocerebellar Ataxia Type 2 (SCA2). In 2021 I became a research fellow at the Molecular Neuroscience and Gene Therapy (MNGT) Laboratory, led by Professor Clévio Nóbrega at the Algarve Biomedical Center Research Institute (ABC-RI), University of Algarve. Professor Clévio Nóbrega’s lab is dedicated to the study of cellular and molecular pathways for hereditary neurodegenerative disorders, such as spinocerebellar Ataxia Type 2 or Type 3, with the goal of developing advanced therapies for these disorders and improve upon existing ones. The project I worked on was funded by the French Muscular Dystrophy Association (AFM-Téléthon) and aimed at addressing the importance of a specific RNA-binding protein in polyglutamine diseases and its therapeutic potential. Recently our lab´s projects have also been aimed at Progeroid Syndromes, as a result professor Clévio Nobrega and I designed a new project aimed at developing novel molecular therapies for Cockayne Syndrome (CS). This project has been financed privately. Our current CS project is focused on assessing the therapeutic potential of FDA-approved molecules and in developing an AAV-based gene-replacement therapy, with the latter approach being of my particular interest. During my research activities, I have developed complete autonomy in a diverse set of techniques including molecular cloning, gene editing, CRISPR/Cas9 based tools design, cell culture, Western blot, production of lentiviral vectors, immunocytochemistry, mice genotyping, mice colony management, animal slices analysis, and statistical analysis. As of now, in my brief academic career I have contributed to eight conference posters and 3 oral conference presentations. Furthermore, I am the author of a review article and co-authored an original article in Quartile 1 peer-reviewed international journals, with both having already been cited two or more times (h-index = 2). Notably, I have supervised one Biomedical Sciences undergraduate student during her BSc dissertation in 2021, and am currently supervising another from the same degree.